Skip to main content
. Author manuscript; available in PMC: 2013 Aug 27.
Published in final edited form as: Respir Med. 2012 Apr 12;106(7):1040–1047. doi: 10.1016/j.rmed.2012.03.006

Table 1.

Characteristics of subjects after stratification on anti-CCP titer.

Low-titer anti-CCP (n =28) Moderate-high titer anti-CCP (n =46)
Median age (range) 67 (20–85) 68 (36–84)
Female gender 18 (64%) 27 (59%)
History of cigarette smoking 16 (57%) 27 (59%)
Current cigarette smokers 3 (11%) 0
First degree relative with RA 3 (11%) 7 (15%)
RF positive 6 (21%) 16 (35%)
Median RF (range) 138 (25–1580) 148 (31–3650)
ANA ≥ 1:320 0 4 (9%)
Median anti-CCP (range) 24 (21–37) 100 (40–235)
Isolated airways disease 17 (61%) 23 (50%)
Isolated ILD 5 (18%) 5 (11%)
Airways disease and ILD 5 (18%) 14 (30%)
Combined pulmonary fibrosis with emphysema 1 (4%) 4 (1%)

ANA=anti-nuclear antibody, CCP=cyclic citrullinated peptide, RF=rheumatoid factor, and ILD=interstitial lung disease.